An observational research registry aims to provide insights into the management of metastatic colorectal cancer.
Taiho Oncology is sponsoring the Choice Registry. The Choice Registry will examine clinical, economic and human-based outcomes in managing metastatic colorectal cancer.
Physicians will enroll approximately 1,000 patients from across the U.S. into the registry.
Continuum Clinical will design and implement the registry.